ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (476 K)

Article Toolbox
  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.pnpbp.2007.10.001    
How to Cite or Link Using DOI (Opens New Window)

Copyright © 2007 Elsevier Inc. All rights reserved.

Δ9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Nobuaki Egashiraa, b, Noriko Ishigamia, Kenichi Mishimaa, Katsunori Iwasakia, Ryozo Oishib and Michihiro Fujiwaraa, Corresponding Author Contact Information, E-mail The Corresponding Author

aDepartment of Neuropharmacology, Faculty of Pharmaceutical Sciences, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan

bDepartment of Pharmacy, Kyushu University Hospital, Fukuoka 812-8582, Japan


Received 14 June 2007; 
revised 1 October 2007; 
accepted 1 October 2007. 
Available online 10 October 2007.

Abstract

Cannabis is the most widely used illicit substance. Δ9-Tetrahydrocannabinol (THC), the major psychoactive component of cannabis, is known to induce cognitive impairment that closely resembles the impairment observed in schizophrenic patients. THC has also been known to impair spatial memory in rats tested in the eight-arm radial maze. We previously reported that microinjection of THC (20 μg/side) into the rat dorsal hippocampus impaired spatial memory and that i.p. injection of THC (6 mg/kg) decreased the extracellular levels of acetylcholine (ACh) in the dorsal hippocampus. In the present study, we compared the effects of olanzapine, an atypical antipsychotic, with those of haloperidol, a typical neuroleptic, on the impairments of spatial memory and decreased ACh levels induced by THC (6 mg/kg, i.p.) in rats. We found that olanzapine (0.1 mg/kg, i.p.) reversed the THC-induced memory deficits and decrease in extracellular ACh levels, whereas haloperidol (0.03–0.3 mg, i.p.) had no effect. These results suggest that olanzapine may improve the THC-induced impairment of spatial memory, partly by enhancing ACh release in the dorsal hippocampus. Therefore, olanzapine could attenuate the acute short-term and working memory deficits induced by cannabis.

Keywords: Acetylcholine; Cannabinoids; Memory; Olanzapine; Radial arm maze

Abbreviations: ACh, acetylcholine; ANOVA, analysis of variance; AChE, acetylcholinesterase; HPLC, high-performance liquid chromatography; PPI, prepulse inhibition; THA, tetrahydroaminoacridine; THC, Δ9-Tetrahydrocannabinol.

Article Outline

1. Introduction
2. Materials and methods
2.1. Animals
2.2. Drugs
2.3. Eight-arm radial maze test
2.4. Brain microdialysis for ACh release
2.5. Statistics
3. Results
3.1. Effects of haloperidol and olanzapine on THC-induced impairment of spatial memory
3.2. Effects of haloperidol and olanzapine on the THC-induced decrease in ACh release in the dorsal hippocampus
4. Discussion
4.1. Effects of haloperidol and olanzapine on THC-induced impairment of spatial memory
4.2. Effects of haloperidol and olanzapine on the THC-induced decrease in ACh release in the dorsal hippocampus
5. Conclusions
Acknowledgements
References





Corresponding Author Contact InformationCorresponding author. Tel.: +81 92 871 6631x6600; fax: +81 92 863 0389.

 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.